(TSM) Taiwan Semiconductor - Overview
Exchange: NYSE •
Country: Taiwan •
Currency: USD •
Type: Common Stock •
ISIN: US8740391003
Stock: Chips, Manufacturing, Fabrication
Total Rating 80
Risk 78
Buy Signal 0.04
| Risk 5d forecast | |
|---|---|
| Volatility | 40.4% |
| Relative Tail Risk | -5.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.06 |
| Alpha | 73.58 |
| Character TTM | |
|---|---|
| Beta | 1.807 |
| Beta Downside | 0.772 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.87% |
| CAGR/Max DD | 1.71 |
EPS (Earnings per Share)
Revenue
Description: TSM Taiwan Semiconductor March 04, 2026
Taiwan Semiconductor Manufacturing Co. (TSM) is a pure-play semiconductor foundry. This business model focuses solely on manufacturing chips designed by other companies.
TSM offers a wide range of wafer fabrication processes. Its products are essential for various electronics, including high-performance computing and smartphones.
The company also provides engineering support, mask manufacturing, and invests in technology startups. TSM operates globally, with significant markets in Asia, North America, and Europe.
To further explore TSMs financial performance and market position, consider researching its detailed financials on ValueRay.
Headlines to watch out for
- Global demand for advanced semiconductors
- Geopolitical tensions impact supply chain stability
- Capital expenditure for leading-edge technology
- Smartphone and HPC market growth
- US-China trade policy on chip technology
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 1722.66b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA -0.10 > 1.0 |
| NWC/Revenue: 61.60% < 20% (prev 63.01%; Δ -1.41% < -1%) |
| CFO/TA 0.29 > 3% & CFO 2291.19b > Net Income 1722.66b |
| Net Debt (-1695.48b) to EBITDA (2896.13b): -0.59 < 3 |
| Current Ratio: 2.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (5.19b) vs 12m ago 0.01% < -2% |
| Gross Margin: 59.90% > 18% (prev 0.56%; Δ 5.93k% > 0.5%) |
| Asset Turnover: 52.30% > 50% (prev 43.25%; Δ 9.05% > 0%) |
| Interest Coverage Ratio: 214.8 > 6 (EBITDA TTM 2896.13b / Interest Expense TTM 9.51b) |
Altman Z'' 8.07
| A: 0.30 (Total Current Assets 3806.38b - Total Current Liabilities 1453.91b) / Total Assets 7910.68b |
| B: 0.59 (Retained Earnings 4691.82b / Total Assets 7910.68b) |
| C: 0.28 (EBIT TTM 2043.09b / Avg Total Assets 7301.31b) |
| D: 2.20 (Book Value of Equity 5420.96b / Total Liabilities 2465.27b) |
| Altman-Z'' Score: 8.07 = AAA |
Beneish M -2.28
| DSRI: 0.78 (Receivables 281.00b/272.09b, Revenue 3818.94b/2894.31b) |
| GMI: 0.94 (GM 59.90% / 56.12%) |
| AQI: 2.40 (AQ_t 0.05 / AQ_t-1 0.02) |
| SGI: 1.32 (Revenue 3818.94b / 2894.31b) |
| TATA: -0.07 (NI 1722.66b - CFO 2291.19b) / TA 7910.68b) |
| Beneish M-Score: -2.28 (Cap -4..+1) = BBB |
What is the price of TSM shares?
As of March 15, 2026, the stock is trading at USD 354.56 with a total of 10,598,277 shares traded.
Over the past week, the price has changed by -0.17%, over one month by -7.66%, over three months by +17.57% and over the past year by +99.42%.
Over the past week, the price has changed by -0.17%, over one month by -7.66%, over three months by +17.57% and over the past year by +99.42%.
Is TSM a buy, sell or hold?
Taiwan Semiconductor has received a consensus analysts rating of 4.59.
Therefore, it is recommended to buy TSM.
- StrongBuy: 11
- Buy: 5
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TSM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 429.5 | 21.1% |
| Analysts Target Price | 429.5 | 21.1% |
TSM Fundamental Data Overview March 13, 2026
Market Cap TWD = 58658.10b (1838.93b USD * 31.898 USD.TWD)
P/E Trailing = 34.1251
P/E Forward = 25.8398
P/S = 0.4828
P/B = 10.8009
P/EG = 1.2564
Revenue TTM = 3818.94b TWD
EBIT TTM = 2043.09b TWD
EBITDA TTM = 2896.13b TWD
Long Term Debt = 896.06b TWD (from longTermDebt, last quarter)
Short Term Debt = 136.54b TWD (from shortTermDebt, last quarter)
Debt = 1064.58b TWD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1695.48b TWD (from netDebt column, last quarter)
Enterprise Value = 56662.73b TWD (58658.10b + Debt 1064.58b - CCE 3059.95b)
Interest Coverage Ratio = 214.8 (Ebit TTM 2043.09b / Interest Expense TTM 9.51b)
EV/FCF = 55.56x (Enterprise Value 56662.73b / FCF TTM 1019.79b)
FCF Yield = 1.80% (FCF TTM 1019.79b / Enterprise Value 56662.73b)
FCF Margin = 26.70% (FCF TTM 1019.79b / Revenue TTM 3818.94b)
Net Margin = 45.11% (Net Income TTM 1722.66b / Revenue TTM 3818.94b)
Gross Margin = 59.90% ((Revenue TTM 3818.94b - Cost of Revenue TTM 1531.48b) / Revenue TTM)
Gross Margin QoQ = 62.33% (prev 59.45%)
Tobins Q-Ratio = 7.16 (Enterprise Value 56662.73b / Total Assets 7910.68b)
Interest Expense / Debt = 0.29% (Interest Expense 3.04b / Debt 1064.58b)
Taxrate = 14.68% (87.77b / 597.96b)
NOPAT = 1743.20b (EBIT 2043.09b * (1 - 14.68%))
Current Ratio = 2.62 (Total Current Assets 3806.38b / Total Current Liabilities 1453.91b)
Debt / Equity = 0.20 (Debt 1064.58b / totalStockholderEquity, last quarter 5404.33b)
Debt / EBITDA = -0.59 (Net Debt -1695.48b / EBITDA 2896.13b)
Debt / FCF = -1.66 (Net Debt -1695.48b / FCF TTM 1019.79b)
Total Stockholder Equity = 4886.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 23.59% (Net Income 1722.66b / Total Assets 7910.68b)
RoE = 35.25% (Net Income TTM 1722.66b / Total Stockholder Equity 4886.97b)
RoCE = 35.33% (EBIT 2043.09b / Capital Employed (Equity 4886.97b + L.T.Debt 896.06b))
RoIC = 32.36% (NOPAT 1743.20b / Invested Capital 5387.48b)
WACC = 12.35% (E(58658.10b)/V(59722.68b) * Re(12.57%) + D(1064.58b)/V(59722.68b) * Rd(0.29%) * (1-Tc(0.15)))
Discount Rate = 12.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.00%
[DCF] Terminal Value 67.50% ; FCFF base≈959.61b ; Y1≈1130.53b ; Y5≈1731.63b
[DCF] Fair Price = 3.34k (EV 15605.57b - Net Debt -1695.48b = Equity 17301.04b / Shares 5.19b; r=12.35% [WACC]; 5y FCF grow 18.98% → 2.90% )
EPS Correlation: 62.72 | EPS CAGR: 24.27% | SUE: 3.82 | # QB: 4
Revenue Correlation: 90.01 | Revenue CAGR: 22.65% | SUE: 0.07 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.44 | Chg7d=-0.006 | Chg30d=+0.252 | Revisions Net=+3 | Analysts=5
EPS current Year (2026-12-31): EPS=14.32 | Chg7d=+0.000 | Chg30d=+0.007 | Revisions Net=+7 | Growth EPS=+34.4% | Growth Revenue=+30.7%
EPS next Year (2027-12-31): EPS=17.97 | Chg7d=-0.025 | Chg30d=+1.520 | Revisions Net=+5 | Growth EPS=+25.6% | Growth Revenue=+23.9%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.6% (Discount Rate 12.6% - Earnings Yield 2.9%)
[Growth] Growth Spread = +18.1% (Analyst 27.7% - Implied 9.6%)
P/E Trailing = 34.1251
P/E Forward = 25.8398
P/S = 0.4828
P/B = 10.8009
P/EG = 1.2564
Revenue TTM = 3818.94b TWD
EBIT TTM = 2043.09b TWD
EBITDA TTM = 2896.13b TWD
Long Term Debt = 896.06b TWD (from longTermDebt, last quarter)
Short Term Debt = 136.54b TWD (from shortTermDebt, last quarter)
Debt = 1064.58b TWD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1695.48b TWD (from netDebt column, last quarter)
Enterprise Value = 56662.73b TWD (58658.10b + Debt 1064.58b - CCE 3059.95b)
Interest Coverage Ratio = 214.8 (Ebit TTM 2043.09b / Interest Expense TTM 9.51b)
EV/FCF = 55.56x (Enterprise Value 56662.73b / FCF TTM 1019.79b)
FCF Yield = 1.80% (FCF TTM 1019.79b / Enterprise Value 56662.73b)
FCF Margin = 26.70% (FCF TTM 1019.79b / Revenue TTM 3818.94b)
Net Margin = 45.11% (Net Income TTM 1722.66b / Revenue TTM 3818.94b)
Gross Margin = 59.90% ((Revenue TTM 3818.94b - Cost of Revenue TTM 1531.48b) / Revenue TTM)
Gross Margin QoQ = 62.33% (prev 59.45%)
Tobins Q-Ratio = 7.16 (Enterprise Value 56662.73b / Total Assets 7910.68b)
Interest Expense / Debt = 0.29% (Interest Expense 3.04b / Debt 1064.58b)
Taxrate = 14.68% (87.77b / 597.96b)
NOPAT = 1743.20b (EBIT 2043.09b * (1 - 14.68%))
Current Ratio = 2.62 (Total Current Assets 3806.38b / Total Current Liabilities 1453.91b)
Debt / Equity = 0.20 (Debt 1064.58b / totalStockholderEquity, last quarter 5404.33b)
Debt / EBITDA = -0.59 (Net Debt -1695.48b / EBITDA 2896.13b)
Debt / FCF = -1.66 (Net Debt -1695.48b / FCF TTM 1019.79b)
Total Stockholder Equity = 4886.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 23.59% (Net Income 1722.66b / Total Assets 7910.68b)
RoE = 35.25% (Net Income TTM 1722.66b / Total Stockholder Equity 4886.97b)
RoCE = 35.33% (EBIT 2043.09b / Capital Employed (Equity 4886.97b + L.T.Debt 896.06b))
RoIC = 32.36% (NOPAT 1743.20b / Invested Capital 5387.48b)
WACC = 12.35% (E(58658.10b)/V(59722.68b) * Re(12.57%) + D(1064.58b)/V(59722.68b) * Rd(0.29%) * (1-Tc(0.15)))
Discount Rate = 12.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.00%
[DCF] Terminal Value 67.50% ; FCFF base≈959.61b ; Y1≈1130.53b ; Y5≈1731.63b
[DCF] Fair Price = 3.34k (EV 15605.57b - Net Debt -1695.48b = Equity 17301.04b / Shares 5.19b; r=12.35% [WACC]; 5y FCF grow 18.98% → 2.90% )
EPS Correlation: 62.72 | EPS CAGR: 24.27% | SUE: 3.82 | # QB: 4
Revenue Correlation: 90.01 | Revenue CAGR: 22.65% | SUE: 0.07 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.44 | Chg7d=-0.006 | Chg30d=+0.252 | Revisions Net=+3 | Analysts=5
EPS current Year (2026-12-31): EPS=14.32 | Chg7d=+0.000 | Chg30d=+0.007 | Revisions Net=+7 | Growth EPS=+34.4% | Growth Revenue=+30.7%
EPS next Year (2027-12-31): EPS=17.97 | Chg7d=-0.025 | Chg30d=+1.520 | Revisions Net=+5 | Growth EPS=+25.6% | Growth Revenue=+23.9%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.6% (Discount Rate 12.6% - Earnings Yield 2.9%)
[Growth] Growth Spread = +18.1% (Analyst 27.7% - Implied 9.6%)